Bank Julius Baer & Co
CVS icon

Bank Julius Baer & Co’s CVS Health CVS Stock Holding History

Bank Julius Baer & Co’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.7K Sell
615
-1,148
-65% -$102K ﹤0.01% 574
2026
Q1 		$127K Sell
1,763
-192
-10% -$14.8K ﹤0.01% 531
2025
Q4 		$155K Sell
1,955
-202
-9% -$15.9K ﹤0.01% 503
2025
Q3 		$163K Buy
2,157
+8
+0.4% +$548 ﹤0.01% 500
2025
Q2 		$148K Sell
2,149
-3
-0.1% -$197 ﹤0.01% 464
2025
Q1 		$146K Buy
2,152
+1,596
+287% +$95.5K ﹤0.01% 444
2024
Q4 		$27.6K Buy
556
+38
+7% +$2.13K ﹤0.01% 586
2024
Q3 		$38.6K Sell
518
-507
-49% -$29.6K ﹤0.01% 478
2024
Q2 		$67.4K Sell
1,025
-114
-10% -$7.13K ﹤0.01% 423
2024
Q1 		$90.9K Sell
1,139
-441
-28% -$33.7K ﹤0.01% 437
2023
Q4 		$125K Sell
1,580
-605
-28% -$43.1K ﹤0.01% 431
2023
Q3 		$153K Sell
2,185
-218
-9% -$15.4K ﹤0.01% 397
2023
Q2 		$166K Sell
2,403
-1,178
-33% -$83.8K ﹤0.01% 426
2023
Q1 		$266K Sell
3,581
-1,372
-28% -$115K ﹤0.01% 406
2022
Q4 		$462K Buy
4,953
+2,661
+116% +$257K ﹤0.01% 349
2022
Q3 		$219K Sell
2,292
-40
-2% -$3.96K ﹤0.01% 394
2022
Q2 		$216K Sell
2,332
-410
-15% -$40K ﹤0.01% 401
2022
Q1 		$278K Buy
2,742
+177
+7% +$18.6K ﹤0.01% 390
2021
Q4 		$265K Buy
2,565
+1,073
+72% +$99.2K ﹤0.01% 507
2021
Q3 		$127K Sell
1,492
-1,504
-50% -$126K ﹤0.01% 609
2021
Q2 		$250K Sell
2,996
-6,419
-68% -$526K ﹤0.01% 543
2021
Q1 		$708K Sell
9,415
-1,830
-16% -$133K 0.01% 383
2020
Q4 		$768K Buy
11,245
+1,250
+13% +$81.3K 0.01% 387
2020
Q3 		$584K Buy
9,995
+2,749
+38% +$171K 0.01% 361
2020
Q2 		$471K Buy
7,246
+1,348
+23% +$84.9K 0.01% 366
2020
Q1 		$350K Buy
+5,898
New +$394K 0.01% 355

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank Julius Baer & Co's CVS Position: Q2 2026 in Review

Bank Julius Baer & Co reduced its CVS Health (CVS) stake by 65% in Q2 2026, selling an estimated $102K and leaving 615 shares worth $63.7K. The position accounts for ﹤0.01% of the portfolio, ranked #574.

Bank Julius Baer & Co first reported a position in CVS in Q1 2020 and has held it in 26 quarters since. The position peaked at $768K in Q4 2020. 2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Bank Julius Baer & Co held 615 shares of CVS Health worth $63.7K as of Q2 2026.
  • Bank Julius Baer & Co sold 1,148 CVS Health shares in Q2 2026, an estimated $102K.
  • CVS Health made up ﹤0.01% of Bank Julius Baer & Co's portfolio in Q2 2026, its #574 holding.
  • Bank Julius Baer & Co first reported a position in CVS Health in Q1 2020 and has held it in 26 quarters since.
  • Bank Julius Baer & Co's CVS Health position peaked at $768K in Q4 2020.
  • 2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Bank Julius Baer & Co's 13F filing for Q2 2026, filed 10 Aug 2026.